位置:首页 > 蛋白库 > TET1_MOUSE
TET1_MOUSE
ID   TET1_MOUSE              Reviewed;        2007 AA.
AC   Q3URK3; Q6ZPK2; Q9CY36;
DT   16-JUN-2009, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 2.
DT   03-AUG-2022, entry version 116.
DE   RecName: Full=Methylcytosine dioxygenase TET1;
DE            EC=1.14.11.n2 {ECO:0000269|PubMed:20639862, ECO:0000269|PubMed:21778364};
DE   AltName: Full=CXXC-type zinc finger protein 6;
DE   AltName: Full=Ten-eleven translocation 1 gene protein homolog;
GN   Name=Tet1; Synonyms=Cxxc6, Kiaa1676;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 655-1066 AND 1773-2007.
RC   STRAIN=C57BL/6J; TISSUE=Liver, and Spinal cord;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1351-1946.
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF HIS-1620 AND ASP-1622.
RX   PubMed=20639862; DOI=10.1038/nature09303;
RA   Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y.;
RT   "Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and
RT   inner cell mass specification.";
RL   Nature 466:1129-1133(2010).
RN   [5]
RP   FUNCTION IN DNA DEMETHYLATION.
RX   PubMed=21496894; DOI=10.1016/j.cell.2011.03.022;
RA   Guo J.U., Su Y., Zhong C., Ming G.L., Song H.;
RT   "Hydroxylation of 5-methylcytosine by TET1 promotes active DNA
RT   demethylation in the adult brain.";
RL   Cell 145:423-434(2011).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=21816367; DOI=10.1016/j.stem.2011.07.010;
RA   Dawlaty M.M., Ganz K., Powell B.E., Hu Y.C., Markoulaki S., Cheng A.W.,
RA   Gao Q., Kim J., Choi S.W., Page D.C., Jaenisch R.;
RT   "Tet1 is dispensable for maintaining pluripotency and its loss is
RT   compatible with embryonic and postnatal development.";
RL   Cell Stem Cell 9:166-175(2011).
RN   [7]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=23352810; DOI=10.1016/j.devcel.2012.12.015;
RA   Dawlaty M.M., Breiling A., Le T., Raddatz G., Barrasa M.I., Cheng A.W.,
RA   Gao Q., Powell B.E., Li Z., Xu M., Faull K.F., Lyko F., Jaenisch R.;
RT   "Combined deficiency of tet1 and tet2 causes epigenetic abnormalities but
RT   is compatible with postnatal development.";
RL   Dev. Cell 24:310-323(2013).
RN   [8]
RP   FUNCTION.
RX   PubMed=21514197; DOI=10.1016/j.molcel.2011.04.005;
RA   Xu Y., Wu F., Tan L., Kong L., Xiong L., Deng J., Barbera A.J., Zheng L.,
RA   Zhang H., Huang S., Min J., Nicholson T., Chen T., Xu G., Shi Y., Zhang K.,
RA   Shi Y.G.;
RT   "Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1
RT   hydroxylase in mouse embryonic stem cells.";
RL   Mol. Cell 42:451-464(2011).
RN   [9]
RP   FUNCTION IN TRANSCRIPTIONAL REPRESSION, AND INTERACTION WITH SIN3A.
RX   PubMed=21490601; DOI=10.1038/nature10066;
RA   Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A.,
RA   Rappsilber J., Helin K.;
RT   "TET1 and hydroxymethylcytosine in transcription and DNA methylation
RT   fidelity.";
RL   Nature 473:343-348(2011).
RN   [10]
RP   FUNCTION IN TRANSCRIPTIONAL REPRESSION.
RX   PubMed=21451524; DOI=10.1038/nature09934;
RA   Wu H., D'Alessio A.C., Ito S., Xia K., Wang Z., Cui K., Zhao K.,
RA   Eve Sun Y., Zhang Y.;
RT   "Dual functions of Tet1 in transcriptional regulation in mouse embryonic
RT   stem cells.";
RL   Nature 473:389-393(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-1620 AND ASP-1622.
RX   PubMed=21778364; DOI=10.1126/science.1210597;
RA   Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C.,
RA   Zhang Y.;
RT   "Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-
RT   carboxylcytosine.";
RL   Science 333:1300-1303(2011).
RN   [12]
RP   FUNCTION, INTERACTION WITH OGT AND HCFC1, AND GLYCOSYLATION.
RX   PubMed=23352454; DOI=10.1016/j.molcel.2012.12.019;
RA   Vella P., Scelfo A., Jammula S., Chiacchiera F., Williams K., Cuomo A.,
RA   Roberto A., Christensen J., Bonaldi T., Helin K., Pasini D.;
RT   "Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to
RT   chromatin in embryonic stem cells.";
RL   Mol. Cell 49:645-656(2013).
RN   [13]
RP   FUNCTION.
RX   PubMed=25284789; DOI=10.1016/j.celrep.2014.08.071;
RA   Takai H., Masuda K., Sato T., Sakaguchi Y., Suzuki T., Suzuki T.,
RA   Koyama-Nasu R., Nasu-Nishimura Y., Katou Y., Ogawa H., Morishita Y.,
RA   Kozuka-Hata H., Oyama M., Todo T., Ino Y., Mukasa A., Saito N.,
RA   Toyoshima C., Shirahige K., Akiyama T.;
RT   "5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by
RT   recruiting the CHTOP-methylosome complex.";
RL   Cell Rep. 9:48-60(2014).
RN   [14]
RP   IDENTIFICATION IN A COMPLEX WITH SIN3A; SINHCAF; HDAC1; RBBP4; SAP30 AND
RP   OGT.
RX   PubMed=28554894; DOI=10.15252/embj.201696307;
RA   Streubel G., Fitzpatrick D.J., Oliviero G., Scelfo A., Moran B., Das S.,
RA   Munawar N., Watson A., Wynne K., Negri G.L., Dillon E.T., Jammula S.,
RA   Hokamp K., O'Connor D.P., Pasini D., Cagney G., Bracken A.P.;
RT   "Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells
RT   required for self-renewal.";
RL   EMBO J. 36:2216-2232(2017).
RN   [15]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=28504700; DOI=10.1038/ng.3868;
RA   Khoueiry R., Sohni A., Thienpont B., Luo X., Velde J.V., Bartoccetti M.,
RA   Boeckx B., Zwijsen A., Rao A., Lambrechts D., Koh K.P.;
RT   "Lineage-specific functions of TET1 in the postimplantation mouse embryo.";
RL   Nat. Genet. 49:1061-1072(2017).
RN   [16]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=31089182; DOI=10.1038/s41598-019-43767-6;
RA   Burleson J.D., Siniard D., Yadagiri V.K., Chen X., Weirauch M.T.,
RA   Ruff B.P., Brandt E.B., Hershey G.K.K., Ji H.;
RT   "TET1 contributes to allergic airway inflammation and regulates interferon
RT   and aryl hydrocarbon receptor signaling pathways in bronchial epithelial
RT   cells.";
RL   Sci. Rep. 9:7361-7361(2019).
RN   [17]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=32855402; DOI=10.1038/s41467-020-18054-y;
RA   Damal Villivalam S., You D., Kim J., Lim H.W., Xiao H., Zushin P.H.,
RA   Oguri Y., Amin P., Kang S.;
RT   "TET1 is a beige adipocyte-selective epigenetic suppressor of
RT   thermogenesis.";
RL   Nat. Commun. 11:4313-4313(2020).
RN   [18]
RP   FUNCTION, INTERACTION WITH NONO, AND SUBCELLULAR LOCATION.
RX   PubMed=32286661; DOI=10.1093/nar/gkaa213;
RA   Li W., Karwacki-Neisius V., Ma C., Tan L., Shi Y., Wu F., Shi Y.G.;
RT   "Nono deficiency compromises TET1 chromatin association and impedes
RT   neuronal differentiation of mouse embryonic stem cells.";
RL   Nucleic Acids Res. 48:4827-4838(2020).
RN   [19]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=33895792; DOI=10.1182/blood.2020008986;
RA   Jiang L., Wang J., Wang K., Wang H., Wu Q., Yang C., Yu Y., Ni P.,
RA   Zhong Y., Song Z., Xie E., Hu R., Min J., Wang F.;
RT   "RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity
RT   by modulating ferroportin degradation.";
RL   Blood 138:689-705(2021).
CC   -!- FUNCTION: Dioxygenase that catalyzes the conversion of the modified
CC       genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC)
CC       and plays a key role in active DNA demethylation (PubMed:21496894).
CC       Also mediates subsequent conversion of 5hmC into 5-formylcytosine
CC       (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC)
CC       (PubMed:21778364). In addition to its role in DNA demethylation, plays
CC       a more general role in chromatin regulation by recruiting histone
CC       modifying protein complexes to alter histone marks and chromatin
CC       accessibility, leading to both activation and repression of gene
CC       expression (PubMed:28504700, PubMed:32286661). Plays therefore a role
CC       in many biological processes and diseases, including stem cell
CC       maintenance, T and B-cell development, inflammation regulation, iron
CC       homeostasis, neural activity or DNA repair (PubMed:31089182,
CC       PubMed:32855402, PubMed:33895792). Involved in the balance between
CC       pluripotency and lineage commitment of cells it plays a role in
CC       embryonic stem cells maintenance and inner cell mass cell specification
CC       (PubMed:28504700). Plays an important role in the tumorigenicity of
CC       glioblastoma cells. TET1-mediated production of 5hmC acts as a
CC       recruitment signal for the CHTOP-methylosome complex to selective sites
CC       on the chromosome, where it methylates H4R3 and activates the
CC       transcription of genes involved in glioblastomagenesis
CC       (PubMed:25284789). Binds preferentially to DNA containing cytidine-
CC       phosphate-guanosine (CpG) dinucleotides over CpH (H=A, T, and C),
CC       hemimethylated-CpG and hemimethylated-hydroxymethyl-CpG (By
CC       similarity). Plays an essential role in the protection and maintenance
CC       of transcriptional and developmental programs together with QSER1 to
CC       inhibit the binding of DNMT3A/3B and therefore de novo methylation (By
CC       similarity). {ECO:0000250|UniProtKB:Q8NFU7,
CC       ECO:0000269|PubMed:20639862, ECO:0000269|PubMed:21451524,
CC       ECO:0000269|PubMed:21490601, ECO:0000269|PubMed:21496894,
CC       ECO:0000269|PubMed:21514197, ECO:0000269|PubMed:21778364,
CC       ECO:0000269|PubMed:23352454, ECO:0000269|PubMed:25284789,
CC       ECO:0000269|PubMed:28504700, ECO:0000269|PubMed:31089182,
CC       ECO:0000269|PubMed:32286661, ECO:0000269|PubMed:32855402,
CC       ECO:0000269|PubMed:33895792}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + a 5-methyl-2'-deoxycytidine in DNA + O2 = a
CC         5-hydroxymethyl-2'-deoxycytidine in DNA + CO2 + succinate;
CC         Xref=Rhea:RHEA:52636, Rhea:RHEA-COMP:11370, Rhea:RHEA-COMP:13315,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:85454, ChEBI:CHEBI:136731;
CC         EC=1.14.11.n2; Evidence={ECO:0000269|PubMed:20639862,
CC         ECO:0000269|PubMed:21778364};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000250|UniProtKB:Q6N021};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250|UniProtKB:Q6N021};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q6N021};
CC       Note=Binds 3 zinc ions per subunit. The zinc ions have a structural
CC       role. {ECO:0000250|UniProtKB:Q6N021};
CC   -!- SUBUNIT: Interacts with SIN3A; recruits the transcriptional co-
CC       repressor SIN3A to gene promoters (PubMed:21490601). Interacts with
CC       HCFC1 and OGT (PubMed:23352454). Found in a complex composed of at
CC       least SINHCAF, SIN3A, HDAC1, SAP30, RBBP4, OGT and TET1
CC       (PubMed:28554894). Interacts with QSER1 (By similarity). Interacts with
CC       NONO (via DNA-binding domain); this interaction recruits TET1 to
CC       genomic loci (PubMed:32286661). {ECO:0000250|UniProtKB:Q8NFU7,
CC       ECO:0000269|PubMed:21490601, ECO:0000269|PubMed:23352454,
CC       ECO:0000269|PubMed:28554894, ECO:0000269|PubMed:32286661}.
CC   -!- INTERACTION:
CC       Q3URK3; Q60520: Sin3a; NbExp=2; IntAct=EBI-4291699, EBI-349034;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20639862}. Chromosome
CC       {ECO:0000269|PubMed:32286661}.
CC   -!- TISSUE SPECIFICITY: Present in embryonic stem cells (ES cells) when its
CC       paralogs TET2 and TET3 are not detectably expressed.
CC       {ECO:0000269|PubMed:20639862, ECO:0000269|PubMed:28504700}.
CC   -!- DOMAIN: The CXXC zinc finger mediates binding to CpG-DNA.
CC       {ECO:0000250|UniProtKB:Q8NFU7}.
CC   -!- PTM: Glycosylated. Interaction with OGT leads to GlcNAcylation.
CC       {ECO:0000269|PubMed:23352454}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype; mice are viable, fertile
CC       and grossly normal, although some mice have a slightly smaller body
CC       size at birth. Embryonic stem cells (ESCs) have reduced levels of 5-
CC       hydroxymethylcytosine (5hmC) and slight changes in global gene
CC       expression, but are pluripotent and support development. However,
CC       deletion mice have an altered response to iron overload
CC       (PubMed:33895792). Mice lacking both Tet1 and Tet2 are fertile, with
CC       females having smaller ovaries and reduced fertility. They display
CC       decreased 5hmC and abnormal methylation at various imprinted loci. ESCs
CC       lacking both Tet1 and Tet2 remain pluripotent but lack 5hmC, leading to
CC       developmental defects in chimeric embryos.
CC       {ECO:0000269|PubMed:21816367, ECO:0000269|PubMed:23352810}.
CC   -!- SIMILARITY: Belongs to the TET family. {ECO:0000305}.
CC   -!- CAUTION: Subsequent steps in cytosine demethylation are subject to
CC       discussion. According to a first model cytosine demethylation occurs
CC       through deamination of 5hmC into 5-hydroxymethyluracil (5hmU) and
CC       subsequent replacement by unmethylated cytosine by the base excision
CC       repair system (PubMed:21496894). According to another model, cytosine
CC       demethylation is rather mediated via conversion of 5hmC into 5fC and
CC       5caC, followed by excision by TDG. {ECO:0000305|PubMed:21496894}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB27288.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC98231.1; Type=Miscellaneous discrepancy; Note=Partially unspliced pre-RNA.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC166359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK010953; BAB27288.1; ALT_INIT; mRNA.
DR   EMBL; AK141438; BAE24685.1; -; mRNA.
DR   EMBL; AK129421; BAC98231.1; ALT_SEQ; Transcribed_RNA.
DR   RefSeq; NP_081660.1; NM_027384.1.
DR   AlphaFoldDB; Q3URK3; -.
DR   SMR; Q3URK3; -.
DR   BioGRID; 206599; 12.
DR   ComplexPortal; CPX-3441; SIN3A histone deacetylase complex, ES cell-specific variant.
DR   IntAct; Q3URK3; 9.
DR   STRING; 10090.ENSMUSP00000133279; -.
DR   iPTMnet; Q3URK3; -.
DR   PhosphoSitePlus; Q3URK3; -.
DR   PaxDb; Q3URK3; -.
DR   PeptideAtlas; Q3URK3; -.
DR   PRIDE; Q3URK3; -.
DR   ProteomicsDB; 262871; -.
DR   Antibodypedia; 14634; 361 antibodies from 30 providers.
DR   Ensembl; ENSMUST00000050826; ENSMUSP00000059527; ENSMUSG00000047146.
DR   UCSC; uc007fje.2; mouse.
DR   MGI; MGI:1098693; Tet1.
DR   VEuPathDB; HostDB:ENSMUSG00000047146; -.
DR   eggNOG; ENOG502QURD; Eukaryota.
DR   GeneTree; ENSGT00940000158935; -.
DR   InParanoid; Q3URK3; -.
DR   OMA; VKEQLMH; -.
DR   OrthoDB; 29059at2759; -.
DR   PhylomeDB; Q3URK3; -.
DR   BioGRID-ORCS; 52463; 0 hits in 77 CRISPR screens.
DR   ChiTaRS; Tet1; mouse.
DR   PRO; PR:Q3URK3; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; Q3URK3; protein.
DR   Bgee; ENSMUSG00000047146; Expressed in trophoblast giant cell and 221 other tissues.
DR   ExpressionAtlas; Q3URK3; baseline and differential.
DR   Genevisible; Q3URK3; MM.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016580; C:Sin3 complex; IC:ComplexPortal.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0008327; F:methyl-CpG binding; ISS:UniProtKB.
DR   GO; GO:0070579; F:methylcytosine dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0006211; P:5-methylcytosine catabolic process; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0048813; P:dendrite morphogenesis; IMP:CACAO.
DR   GO; GO:0080111; P:DNA demethylation; IDA:MGI.
DR   GO; GO:0001826; P:inner cell mass cell differentiation; IMP:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IC:ComplexPortal.
DR   GO; GO:0090310; P:negative regulation of DNA methylation-dependent heterochromatin assembly; ISO:MGI.
DR   GO; GO:1902455; P:negative regulation of stem cell population maintenance; IC:ComplexPortal.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IC:ComplexPortal.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IC:ComplexPortal.
DR   GO; GO:0070989; P:oxidative demethylation; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0031062; P:positive regulation of histone methylation; ISS:UniProtKB.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; IC:ComplexPortal.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IMP:UniProtKB.
DR   GO; GO:0044030; P:regulation of DNA methylation; IMP:MGI.
DR   GO; GO:2000653; P:regulation of genetic imprinting; IMP:MGI.
DR   GO; GO:0019827; P:stem cell population maintenance; IMP:UniProtKB.
DR   InterPro; IPR024779; 2OGFeDO_noxygenase_dom.
DR   InterPro; IPR040175; TET1/2/3.
DR   InterPro; IPR002857; Znf_CXXC.
DR   PANTHER; PTHR23358; PTHR23358; 1.
DR   Pfam; PF12851; Tet_JBP; 1.
DR   Pfam; PF02008; zf-CXXC; 1.
DR   SMART; SM01333; Tet_JBP; 1.
DR   PROSITE; PS51058; ZF_CXXC; 1.
PE   1: Evidence at protein level;
KW   Activator; Chromatin regulator; Chromosome; Dioxygenase; DNA-binding;
KW   Glycoprotein; Iron; Metal-binding; Nucleus; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..2007
FT                   /note="Methylcytosine dioxygenase TET1"
FT                   /id="PRO_0000377549"
FT   ZN_FING         567..608
FT                   /note="CXXC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   REGION          1..79
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          119..168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          227..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          512..657
FT                   /note="Sufficient for binding to genomic CpG islands"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   REGION          613..670
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          711..735
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          820..859
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          882..906
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          964..993
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1050..1129
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1209..1240
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1322..1341
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1528..1541
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   REGION          1702..1728
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1798..1869
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..65
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        148..168
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        227..284
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        625..640
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        655..670
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        713..735
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        821..835
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1050..1064
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1077..1092
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1094..1114
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1115..1129
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1215..1240
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1714..1728
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1814..1844
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1845..1867
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         574
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         577
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         580
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         586
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         589
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         592
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         602
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         607
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         1371
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1373
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1430
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1456
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1458
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1499
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1509
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1511
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1527
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1536
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1596
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1612
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1618
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1620
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1622
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1625
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1653
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1907
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1922..1924
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1928..1930
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   BINDING         1938
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6N021"
FT   MOD_RES         854
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU7"
FT   MUTAGEN         1620
FT                   /note="H->Y: Loss of enzyme activity; when associated with
FT                   A-1622."
FT                   /evidence="ECO:0000269|PubMed:20639862,
FT                   ECO:0000269|PubMed:21778364"
FT   MUTAGEN         1622
FT                   /note="D->A: Loss of enzyme activity; when associated with
FT                   Y-1620."
FT                   /evidence="ECO:0000269|PubMed:20639862,
FT                   ECO:0000269|PubMed:21778364"
SQ   SEQUENCE   2007 AA;  219261 MW;  C563672511ACFFC6 CRC64;
     MSRSRPAKPS KSVKTKLQKK KDIQMKTKTS KQAVRHGASA KAVNPGKPKQ LIKRRDGKKE
     TEDKTPTPAP SFLTRAGAAR MNRDRNQVLF QNPDSLTCNG FTMALRRTSL SWRLSQRPVV
     TPKPKKVPPS KKQCTHNIQD EPGVKHSEND SVPSQHATVS PGTENGEQNR CLVEGESQEI
     TQSCPVFEER IEDTQSCISA SGNLEAEISW PLEGTHCEEL LSHQTSDNEC TSPQECAPLP
     QRSTSEVTSQ KNTSNQLADL SSQVESIKLS DPSPNPTGSD HNGFPDSSFR IVPELDLKTC
     MPLDESVYPT ALIRFILAGS QPDVFDTKPQ EKTLITTPEQ VGSHPNQVLD ATSVLGQAFS
     TLPLQWGFSG ANLVQVEALG KGSDSPEDLG AITMLNQQET VAMDMDRNAT PDLPIFLPKP
     PNTVATYSSP LLGPEPHSST SCGLEVQGAT PILTLDSGHT PQLPPNPESS SVPLVIAANG
     TRAEKQFGTS LFPAVPQGFT VAAENEVQHA PLDLTQGSQA APSKLEGEIS RVSITGSADV
     KATAMSMPVT QASTSSPPCN STPPMVERRK RKACGVCEPC QQKANCGECT YCKNRKNSHQ
     ICKKRKCEVL KKKPEATSQA QVTKENKRPQ REKKPKVLKT DFNNKPVNGP KSESMDCSRR
     GHGEEEQRLD LITHPLENVR KNAGGMTGIE VEKWAPNKKS HLAEGQVKGS CDANLTGVEN
     PQPSEDDKQQ TNPSPTFAQT IRNGMKNVHC LPTDTHLPLN KLNHEEFSKA LGNNSSKLLT
     DPSNCKDAMS VTTSGGECDH LKGPRNTLLF QKPGLNCRSG AEPTIFNNHP NTHSAGSRPH
     PPEKVPNKEP KDGSPVQPSL LSLMKDRRLT LEQVVAIEAL TQLSEAPSES SSPSKPEKDE
     EAHQKTASLL NSCKAILHSV RKDLQDPNVQ GKGLHHDTVV FNGQNRTFKS PDSFATNQAL
     IKSQGYPSSP TAEKKGAAGG RAPFDGFENS HPLPIESHNL ENCSQVLSCD QNLSSHDPSC
     QDAPYSQIEE DVAAQLTQLA STINHINAEV RNAESTPESL VAKNTKQKHS QEKRMVHQKP
     PSSTQTKPSV PSAKPKKAQK KARATPHANK RKKKPPARSS QENDQKKQEQ LAIEYSKMHD
     IWMSSKFQRF GQSSPRSFPV LLRNIPVFNQ ILKPVTQSKT PSQHNELFPP INQIKFTRNP
     ELAKEKVKVE PSDSLPTCQF KTESGGQTFA EPADNSQGQP MVSVNQEAHP LPQSPPSNQC
     ANIMAGAAQT QFHLGAQENL VHQIPPPTLP GTSPDTLLPD PASILRKGKV LHFDGITVVT
     EKREAQTSSN GPLGPTTDSA QSEFKESIMD LLSKPAKNLI AGLKEQEAAP CDCDGGTQKE
     KGPYYTHLGA GPSVAAVREL METRFGQKGK AIRIEKIVFT GKEGKSSQGC PVAKWVIRRS
     GPEEKLICLV RERVDHHCST AVIVVLILLW EGIPRLMADR LYKELTENLR SYSGHPTDRR
     CTLNKKRTCT CQGIDPKTCG ASFSFGCSWS MYFNGCKFGR SENPRKFRLA PNYPLHEKQL
     EKNLQELATV LAPLYKQMAP VAYQNQVEYE EVAGDCRLGN EEGRPFSGVT CCMDFCAHSH
     KDIHNMHNGS TVVCTLIRAD GRDTNCPEDE QLHVLPLYRL ADTDEFGSVE GMKAKIKSGA
     IQVNGPTRKR RLRFTEPVPR CGKRAKMKQN HNKSGSHNTK SFSSASSTSH LVKDESTDFC
     PLQASSAETS TCTYSKTASG GFAETSSILH CTMPSGAHSG ANAAAGECTG TVQPAEVAAH
     PHQSLPTADS PVHAEPLTSP SEQLTSNQSN QQLPLLSNSQ KLASCQVEDE RHPEADEPQH
     PEDDNLPQLD EFWSDSEEIY ADPSFGGVAI APIHGSVLIE CARKELHATT SLRSPKRGVP
     FRVSLVFYQH KSLNKPNHGF DINKIKCKCK KVTKKKPADR ECPDVSPEAN LSHQIPSRVA
     STLTRDNVVT VSPYSLTHVA GPYNRWV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024